Dymista® Knowledge

Allergic Rhinitis Complications and Diagnosis

understanding-allergic-rhinitis

Allergic rhinitis is inflammation of the membranes lining the nose, which occurs when they become sensitised to allergens.1 It is a very common condition, estimated to affect around one in every five people in the UK. A person with allergic rhinitis typically presents with..

Read more

Allergic rhinitis has an impact on patients, not just in the summer months, but all year round. In fact, 59% of allergic rhinitis patients have persistent symptoms,1 which have an impact on their daily activities.2 A study has shown that 74% of perennial allergic rhinitis sufferers have a moderate to…

Read more
treatment-allergic-rhinitis
impact-of-allergic-rhinitis-onsleep

Allergic rhinitis has a real impact on patients’ sleep and general well-being.1 Patients suffering from allergic rhinitis have reported the following..

Read more

In our last email, we highlighted how allergic rhinitis affect patients sleep, but what affect does this have on work productivity and school performance? As you can imagine, it can have a lasting impact. In fact, as a result of...

Read more
allergic-rhinitis-productivity

Comparison of Allergic Rhinitis Treatment Options

effective-next-step-treatment

Effective treatment when monotherapy is not considered sufficient
Dymista® has been shown to be twice as effective as fluticasone propionate or azelastine alone at treating the entire rhinitis symptom..

Read more

In a randomised, double-blind, placebo-controlled, 2-week trial involving 779 patients with moderate-to-severe seasonal allergic rhinitis...

Read more
onset-action-clinical-practice
recommented-treatment

Dymista® is recommended for use as part of a stepwise pharmacological treatment algorithm by both the BSACI and the Stirling Consensus.1,2...

Read more

Dymista® leads to greater symptom improvement than using either azelastine or fluticasone propionate alone.1

Read more
full-spectrum-allergic-rhinitis

Best Practice of Dymista®

correct-administration-for-optimum-efficacy

The correct use of Dymista® is imperative for optimum efficacy and to minimise side effects. Patients should be shown how to use Dymista® following the simple step by step instructions or watching the how to use video..

Read more

Dymista® is suitable for long-term use For perennial allergic rhinitis patients to get the futl therapeutic benefit, regular use of treatment is essential. With Dymista®, the duration of treatment should correspond to the period of allergenic exposure and...

Read more
suitable-for-longterm-use
convenient-effective-symptom-control

We need to manage allergic rhinitis as effectively as we can. Dymista® provides rapid symptom relief across the entire rhinitis spectrum, allowing the patient to continue with everyday life..

Read more

It is important to remember that Dymista® contains two active ingredients, fluticasone propionate, an intranasal steroid and azelastine an intranasal antihistamine. Antihistamines work quickly to alleviate the immediate symptoms of..

Read more
dual-action-combination

References superscripted in the article preview text are made available on the corresponding pages.

The website you are trying to access is designed for healthcare professionals in the UK, the content is not designed for the general public.

Are you a UK healthcare professional?

YES
NO

hcp popup title

Mylan Connects is an online platform for UK health Professionals.

Across the website you will find news, blogs and product information.

Register to Mylan Connects today

Please note that the website contains promotional and non-promotional material including educational content and resources to help you and your patients.

REGISTER NOW